tiprankstipranks
Sartorius Stedim Biotech (FR:DIM)
:DIM
France Market

Sartorius Stedim Biotech (DIM) Income Statement

Compare
11 Followers

Sartorius Stedim Biotech Income Statement

Last quarter (Q4 2024), Sartorius Stedim Biotech's total revenue was €751.30M, an increase of 6.30% from the same quarter last year. In Q4, Sartorius Stedim Biotech's net income was €45.60M. See Sartorius Stedim Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.78B€ 2.78B€ 3.49B€ 2.89B€ 1.91B
Gross Profit
€ 1.21B€ 1.23B€ 1.83B€ 1.55B€ 1.00B
Operating Expenses
€ 836.10M€ 749.00M€ 751.70M€ 670.02M€ 499.88M
Depreciation and Amortization
€ 301.70M€ 237.60M€ 181.70M€ 141.56M€ 101.69M
EBITDA
€ 670.50M€ 755.70M€ 1.35B€ 811.96M€ 623.79M
Operating Income
€ 370.60M€ 484.50M€ 995.20M€ 683.30M€ 471.81M
Other Income/Expenses
€ -151.40M€ -83.40M€ 135.20M€ -36.60M€ -11.02M
Pretax Income
€ 219.20M€ 401.10M€ 1.13B€ 646.72M€ 482.63M
Net Income
€ 175.10M€ 309.70M€ 876.10M€ 414.40M€ 335.93M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 1.81€ 3.36€ 9.51€ 4.50€ 3.64
Diluted EPS
€ 1.81€ 3.36€ 9.51€ 4.50€ 3.64
Weighted Average Shares Outstanding
96.78M 92.16M 92.16M 92.18M 92.18M
Weighted Average Shares Outstanding (Diluted)
96.78M 92.16M 92.16M 92.18M 92.18M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis